424 related articles for article (PubMed ID: 20807574)
1. The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays.
Babic A; Loftin IR; Stanislaw S; Wang M; Miller R; Warren SM; Zhang W; Lau A; Miller M; Wu P; Padilla M; Grogan TM; Pestic-Dragovich L; McElhinny AS
Methods; 2010 Dec; 52(4):287-300. PubMed ID: 20807574
[TBL] [Abstract][Full Text] [Related]
2. Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer.
Moatamed NA; Nanjangud G; Pucci R; Lowe A; Shintaku IP; Shapourifar-Tehrani S; Rao N; Lu DY; Apple SK
Am J Clin Pathol; 2011 Nov; 136(5):754-61. PubMed ID: 22031314
[TBL] [Abstract][Full Text] [Related]
3. Fixation conditions for DNA and RNA in situ hybridization: a reassessment of molecular morphology dogma.
Tbakhi A; Totos G; Hauser-Kronberger C; Pettay J; Baunoch D; Hacker GW; Tubbs RR
Am J Pathol; 1998 Jan; 152(1):35-41. PubMed ID: 9422521
[TBL] [Abstract][Full Text] [Related]
4. Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
Yamashita-Kashima Y; Shu S; Yorozu K; Hashizume K; Moriya Y; Fujimoto-Ouchi K; Harada N
Gastric Cancer; 2014 Oct; 17(4):638-47. PubMed ID: 24414131
[TBL] [Abstract][Full Text] [Related]
5. Effect of fixation time on breast biomarker expression: a controlled study using cell line-derived xenografted (CDX) tumours.
Kao KR; Hasan T; Baptista A; Truong T; Gai L; Smith AC; Li S; Gonzales P; Voisey K; Eriwvo P; Power J; Denic N
J Clin Pathol; 2017 Oct; 70(10):832-837. PubMed ID: 28341657
[TBL] [Abstract][Full Text] [Related]
6. Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis.
Sathyanarayana UG; Birch C; Nagle RB; Tomlins SA; Palanisamy N; Zhang W; Hubbard A; Brunhoeber P; Wang Y; Tang L
Appl Immunohistochem Mol Morphol; 2015; 23(5):364-73. PubMed ID: 25265431
[TBL] [Abstract][Full Text] [Related]
7. RCL2, a potential formalin substitute for tissue fixation in routine pathological specimens.
Masir N; Ghoddoosi M; Mansor S; Abdul-Rahman F; Florence CS; Mohamed-Ismail NA; Tamby MR; Md-Latar NH
Histopathology; 2012 Apr; 60(5):804-15. PubMed ID: 22320393
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous analysis of HER2 gene and protein on a single slide facilitates HER2 testing of breast and gastric carcinomas.
Hirschmann A; Lamb TA; Marchal G; Padilla M; Diebold J
Am J Clin Pathol; 2012 Dec; 138(6):837-44. PubMed ID: 23161718
[TBL] [Abstract][Full Text] [Related]
9. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
Akhdar A; Bronsard M; Lemieux R; Geha S
Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
[TBL] [Abstract][Full Text] [Related]
10. The innovative safe fixative for histology, histopathology, and immunohistochemistry techniques: "pilot study using shellac alcoholic solution fixative".
Ali Jamal A; Abd El-Aziz GS; Hamdy RM; Al-Hayani A; Al-Maghrabi J
Microsc Res Tech; 2014 May; 77(5):385-93. PubMed ID: 24633954
[TBL] [Abstract][Full Text] [Related]
11. External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.
Bartlett JM; Ibrahim M; Jasani B; Morgan JM; Ellis I; Kay E; Connolly Y; Campbell F; O'Grady A; Barnett S; Miller K
Am J Clin Pathol; 2009 Jan; 131(1):106-11. PubMed ID: 19095573
[TBL] [Abstract][Full Text] [Related]
12. HistoChoice as an alternative to formalin fixation of undecalcified bone specimens.
Kacena MA; Troiano NW; Coady CE; Horowitz MC
Biotech Histochem; 2004; 79(5-6):185-90. PubMed ID: 15764285
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.
Sauter G; Lee J; Bartlett JM; Slamon DJ; Press MF
J Clin Oncol; 2009 Mar; 27(8):1323-33. PubMed ID: 19204209
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dual-color dual-hapten brightfield in situ hybridization (DDISH) and fluorescence in situ hybridization in breast cancer HER2 assessment.
Kosa C; Kardos L; Kovacs J; Szollosi Z
Pathol Res Pract; 2013 Mar; 209(3):147-50. PubMed ID: 23419693
[TBL] [Abstract][Full Text] [Related]
15. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
[TBL] [Abstract][Full Text] [Related]
16. Protocol for HER2 FISH determination on PAXgene-fixed and paraffin-embedded tissue in breast cancer.
Oberauner-Wappis L; Loibner M; Viertler C; Groelz D; Wyrich R; Zatloukal K
Int J Exp Pathol; 2016 Apr; 97(2):202-6. PubMed ID: 27273709
[TBL] [Abstract][Full Text] [Related]
17. Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation.
Penault-Llorca F; Adelaïde J; Houvenaeghel G; Hassoun J; Birnbaum D; Jacquemier J
J Pathol; 1994 May; 173(1):65-75. PubMed ID: 7931839
[TBL] [Abstract][Full Text] [Related]
18. Short formalin fixation and rapid microwave processing do not affect HER2 testing.
Sassi I; Invernizzi F; Doglioni C
Recent Results Cancer Res; 2015; 199():55-64. PubMed ID: 25636429
[TBL] [Abstract][Full Text] [Related]
19. The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methods.
Yan F; Wu X; Crawford M; Duan W; Wilding EE; Gao L; Nana-Sinkam SP; Villalona-Calero MA; Baiocchi RA; Otterson GA
Methods; 2010 Dec; 52(4):281-6. PubMed ID: 20888418
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid quality preservation by an alcohol-based fixative: comparison with frozen tumors in a routine pathology setting.
Hostein I; Stock N; Soubeyran I; Marty M; De Mascarel I; Bui M; Geneste G; Petersen MC; Coindre JM; Macgrogan G
Diagn Mol Pathol; 2011 Mar; 20(1):52-62. PubMed ID: 21326040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
